2022
DOI: 10.1016/j.compbiomed.2022.105468
|View full text |Cite
|
Sign up to set email alerts
|

Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
32
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 46 publications
(33 citation statements)
references
References 53 publications
1
32
0
Order By: Relevance
“…Similarly, the EU approved Moderna mRNA for administration to older children 12 and up in July 2021. All these approvals were based on positive short-term trial results [ 6 , 7 ]. Vaccine against COVID-19 recommendations vary by country, especially when it comes to children.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, the EU approved Moderna mRNA for administration to older children 12 and up in July 2021. All these approvals were based on positive short-term trial results [ 6 , 7 ]. Vaccine against COVID-19 recommendations vary by country, especially when it comes to children.…”
Section: Introductionmentioning
confidence: 99%
“…During simulation, the protein's structural alterations and insights from RMSD analysis support the protein's stability and equilibrium. The higher stability of the protein-ligand complex is indicated by the lower RMSD value of the protein backbone [ 55 ]. Fig.…”
Section: Resultsmentioning
confidence: 99%
“…As they are genetically unique to each patient, tissue organoid has provided alternative ways of preclinical drug testing and are now being used for the development of “personalized medicine” for several diseases. Organoids have been effectively generated and their application has been demonstrated in various fields, including drug screening, disease modeling, tissue transplant, pathogenesis, and regenerative medicine (Ashok et al, 2020; Parihar, Ferdous Sonia, et al, 2022; Parihar, Puranik, et al, 2022; Parihar, Sonia, et al, 2022; Parihar, Zafar, et al, 2022). In vitro models are more reproducible, permitting a larger sample size to be evaluated on multiple models in a smaller duration of time.…”
Section: Introductionmentioning
confidence: 99%